Hutchmed investor relations
WebHUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted ... WebHUTCHMED (Nasdaq/AIM:HCM;HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and …
Hutchmed investor relations
Did you know?
WebSep 9, 2024 · Morgan Stanley 19th Annual Global Healthcare Conference. September 9, 2024 10:15 AM ET. Webcast. WebApr 11, 2024 · Investor Relations GlobeNewswire Intended Retirement of Independent Non-executive Director Provided by ... N.J., April 11, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ...
WebHUTCHMED 9,368 followers 2w We will be announcing our 2024 Final Results on Tuesday, February 28, 2024. Our management team will host a conference call and webcast for investors and analysts at... WebMar 3, 2024 · Current report filing. January 05, 2024. Download Download Download Download Download. 4. Statement of Changes in Beneficial Ownership. December 29, 2024. Download Download Download Download. 8-K. Current report filing.
WebMay 26, 2024 · NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HUTCHMED (China) Limited (“Hutchmed” or the “Company”) (NASDAQ: HCM). WebJan 23, 2024 · HUTCHMED Limited will receive up to US$1.13 billion including US$400 million upfront on closing as well as potential regulatory, development and commercial …
WebApr 4, 2024 · HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
WebJun 23, 2024 · The company has already secured five cornerstone investors for the listing: Carlyle Group, the Canada Pension Plan Investment Board, General Atlantic, HBM Healthcare Investments and CICC. The... j crew women\u0027s sweater saleWebJan 25, 2024 · Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ... lsw wallbox energy controlWebJun 23, 2024 · About HUTCHMED. HUTCHMED (Nasdaq/AIM: HCM) (formerly Hutchison China MediTech) is an innovative, commercial-stage, biopharmaceutical company. lsx performance ukWebFeb 28, 2024 · HUTCHMED will be eligible to receive up to $1.13 billion, including $400 million upfront on closing of the agreement and up to $730 million in additional potential … j.crew wool harbor pea coatWebApr 12, 2024 · HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted... j crew wool blend turtleneck sweaterlsx accessory driveWebApr 4, 2024 · As of April 4, 2024, HUTCHMED (China) Ltd (ADR)’s stock price is $13.24, which is up 6.26% from its previous closing price. At AAII, we stress that investors should never buy or sell a stock solely based on its stock … lsx racing